Can low-dose interferon prevent relapse of hepatitis C virus infection?
(Mary Ann Liebert, Inc./Genetic Engineering News) Chronic hepatitis C virus (HCV) infection can lead to serious diseases such as cirrhosis and cancer of the liver, so viral clearance and prevention of relapse are important treatment goals. Low-dose oral interferon may reduce the risk of HCV relapse in patients with mild liver fibrosis according to a study published in Journal of Interferon & Cytokine Research. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - March 5, 2014 Category: Global & Universal Source Type: news

Liver metabolism study could help patients awaiting transplants
(Rice University) In a new study that could help doctors extend the lives of patients awaiting liver transplants, a Rice University-led team of researchers examined the metabolic breakdown that takes place in liver cells during late-stage cirrhosis and found clues that suggest new treatments to delay liver failure. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - March 3, 2014 Category: Biology Source Type: news

What Are the Potential Side Effects of Iron Therapy?
Discussion Anemia is a common problem in pediatrics with an estimated 25% of school age children worldwide being anemic. It can cause cognitive and developmental problems along with impaired immunity. It is defined as “a lower than normal value for the related measurements of hemoglobin, hematocrit, and number of red blood cells”, usually 2 standard deviations below the normal for age. Normal hematological values change with age. The most common type of anemia in childhood is iron deficiency commonly caused by inadequate stores (e.g. premature infant), inadequate intake (e.g. poor nutrition) or blood loss (e.g....
Source: PediatricEducation.org - March 3, 2014 Category: Pediatrics Authors: pediatriceducationmin Tags: Uncategorized Source Type: news

Tanzania: Concern As Liver Disease Cases Rise
[Daily News]GASTROLOGICAL and digestion medical practitioners in the country are increasingly worried following the rising cases of people suffering from liver cancer brought about by Hepatitis B, C and Cirrhosis or liver shrinking. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - January 25, 2014 Category: African Health Source Type: news

Primary Biliary Cirrhosis
Title: Primary Biliary CirrhosisCategory: Diseases and ConditionsCreated: 12/31/1997 12:00:00 AMLast Editorial Review: 1/9/2014 12:00:00 AM (Source: MedicineNet Digestion General)
Source: MedicineNet Digestion General - January 9, 2014 Category: Nutrition Source Type: news

NIH grant funds national study on treatments for alcoholic hepatitis
UT Southwestern has launched the local arm of a national, multicenter study aimed at finding more effective treatments for alcoholic hepatitis, a disease of the liver that often leads to cirrhosis and death in severe cases. (Source: UT Southwestern Medical Center News)
Source: UT Southwestern Medical Center News - December 19, 2013 Category: Hospital Management Source Type: news

Novel pump being trialled at the Royal Free is giving patients with liver disease a new lease of life
Patients being treated for liver disease at the Royal Free Hospital are having their lives transformed thanks to a simple pump that is implanted in the abdomen.A liver transplant is often the only option for patients with severe alcohol-related liver disease and around 4,000 people in the UK die of the condition every year.However, new technology being trialled at the Royal Free has given some patients with liver disease or cirrhosis a new lease on life. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - December 6, 2013 Category: Consumer Health News Tags: Liver Disease / Hepatitis Source Type: news

The Landscape of the MHE-Associated Gut MicrobiomeThe Landscape of the MHE-Associated Gut Microbiome
Could elucidating the minimal hepatic encephalopathy (MHE)-associated gut microbiome help predict and lower the high risk for MHE in patients with cirrhosis? The American Journal of Gastroenterology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - December 5, 2013 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

Tox on the Web
“Krokodil” Hype: In a piece posted at Slate, Justin Peters cuts through the nonsense regarding just how fast use of “krokodil” is spreading in the U.S., and concludes there are much more important threats to worry about. Dangerous Bali High: The Irish Mirror reports that in the months of August and September of this year, 52 people have died of methanol poisoning after drinking tainted Arak — a local spirit — in Bali. This is an ongoing problem — TPR has reported on it before. The Power of Poison: In the New York Times, Edward Rothstein reviews th...
Source: The Poison Review - November 20, 2013 Category: Toxicology Authors: Leon Tags: Medical bali benzodiazepines desomorphine hepatic failure krokodil laundry pods liver disease methanol poisonin oxyelite tox on the web Source Type: news

How the immune system induces liver damage during hepatitis
Viral infections are the primary cause of liver inflammation or hepatitis, affecting hundreds of millions of people all over the world, and they represent a public health problem worldwide. The acute condition can cause irreversible damage to the liver, and if not cured can become chronic, leading to serious diseases such as cirrhosis or cancer... (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - November 12, 2013 Category: Consumer Health News Tags: Liver Disease / Hepatitis Source Type: news

New antivirals eradicate hepatitis C in trial
Sofosbuvir and ledipasvir stop virus replicating in 97% of patients in study reported in the Lancet journalScientists have reported the successful eradication of hepatitis C in patients using two new antiviral drugs, raising hopes of a possible cure.In the trial, the virus was eliminated from almost all the patients involved, including those who had not previously responded to existing drugs.Hepatitis C is caused by a virus that spreads via bodily fluids and ends up damaging the liver. Unlike other forms of hepatitis, there is no vaccine and the only treatments include powerful combinations of drugs known as interferons an...
Source: Guardian Unlimited Science - November 5, 2013 Category: Science Authors: Alok Jha Tags: theguardian.com United States News Health Medical research Society Drugs Hepatitis C Cancer UK news Science Source Type: news

FibroScan: fast, painless alternative to liver biopsies for hepatitis patients
A non-invasive alternative to liver biopsy, now the standard method of diagnosing cirrhosis in hepatitis patients, proved very reliable in a national multi-center study including Henry Ford Hospital. The results of the study are good news for chronic hepatitis B and C sufferers who now often undergo repeated and potentially painful liver biopsies as part of their disease management. The focus of the research was the French-made FibroScan, which was being used in more than 70 countries worldwide when it received approval by the U.S. Food and Drug Administration in April... (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - November 4, 2013 Category: Consumer Health News Tags: Liver Disease / Hepatitis Source Type: news

Estrogen protects women with NASH from severe liver fibrosis
New research suggests that estrogen protects women with nonalcoholic steatohepatitis (NASH) from severe liver fibrosis. According to the study published online in Hepatology, a journal of the American Association for the Study of Liver Diseases, men are at higher risk of more severe fibrosis compared to women prior to menopause, but liver fibrosis severity is similar in men and post-menopausal women. Non-alcoholic fatty liver disease (NAFLD) includes a range of liver disorders from simple fatty liver to inflammation, fibrosis, and cirrhosis... (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - November 1, 2013 Category: Consumer Health News Tags: Liver Disease / Hepatitis Source Type: news

Study: Fast, painless alternative to liver biopsies for hepatitis patients proves accurate and reliable
(Henry Ford Health System) A non-invasive alternative to liver biopsy, now the standard method of diagnosing cirrhosis in hepatitis patients, proved very reliable in a national multi-center study including Henry Ford Hospital.The results of the study are good news for chronic hepatitis B and C sufferers who now often undergo repeated and potentially painful liver biopsies as part of their disease management. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - October 31, 2013 Category: Global & Universal Source Type: news

FDA advisory committee recommends approval of simeprevir for combination treatment of genotype 1 chronic hepatitis C in adult patients
Janssen Research & Development, LLC (Janssen) announced today that the Antiviral Drugs Advisory Committee of the U.S. Food and Drug Administration (FDA) voted unanimously (19 to 0) to recommend approval of the investigational protease inhibitor simeprevir (TMC435) administered once daily as a 150 mg capsule with pegylated interferon and ribavirin for the treatment of genotype 1 chronic hepatitis C in adult patients with compensated liver disease, including cirrhosis... (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - October 30, 2013 Category: Consumer Health News Tags: Liver Disease / Hepatitis Source Type: news

Cirrhosis (Liver)
Title: Cirrhosis (Liver)Category: Diseases and ConditionsCreated: 12/31/1997 12:00:00 AMLast Editorial Review: 10/23/2013 12:00:00 AM (Source: MedicineNet Crohn's Disease General)
Source: MedicineNet Crohn's Disease General - October 23, 2013 Category: Gastroenterology Source Type: news

'Liver cirrhosis from binge drinking made me look pregnant'
Jo, 35, is one of many disturbing stories appearing on a TV show airing tonight. Called Old Before My Time, it shows the horrific damage young people are doing to their bodies through excessive drinking. (Source: the Mail online | Health)
Source: the Mail online | Health - October 21, 2013 Category: Consumer Health News Source Type: news

Higher rates of liver cancer in men explained by Men-only hepatitis B mutation
A team of researchers has identified a novel mutation in the hepatitis B virus (HBV) in Korea that appears only in men and could help explain why HBV-infected men are roughly five times more likely than HBV-infected women to develop liver cancer. Although some women do progress to cirrhosis and liver cancer, the mutation is absent in HBV in women. The research is published ahead of print in the Journal of Clinical Microbiology... (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - October 21, 2013 Category: Consumer Health News Tags: Liver Disease / Hepatitis Source Type: news

Men-only hepatitis B mutation explains higher cancer rates
(American Society for Microbiology) A team of researchers has identified a novel mutation in the hepatitis B virus (HBV) in Korea that appears only in men and could help explain why HBV-infected men are roughly five times more likely than HBV-infected women to develop liver cancer. Although some women do progress to cirrhosis and liver cancer, the mutation is absent in HBV in women. The research is published ahead of print in the Journal of Clinical Microbiology. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - October 17, 2013 Category: Global & Universal Source Type: news

Assessing the Effect of Simvastatin in PBCAssessing the Effect of Simvastatin in PBC
Is simvastatin an effective drug therapy in the treatment of primary biliary cirrhosis? Liver International (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - October 14, 2013 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

Researchers Determine That Individuals’ ‘Breathprint’ Are Unique; May Have Potential for Clinical Laboratory Testing When Coupled With Mass Spectrometry Technology
Pathologists may be interested to learn that everyone’s breath reveals a signature composition of metabolites that may reflect a lifetime of diet, state of health, illnesses, and exposure to chemicals New research shows that a person’s “breathprint” is as unique as a fingerprint and may be as effective as bodily fluids in diagnosing diseases. That […] (Source: Dark Daily)
Source: Dark Daily - October 14, 2013 Category: Laboratory Medicine Authors: jude Tags: Instruments & Equipment Laboratory Management and Operations Laboratory News Laboratory Pathology BMI body mass index breathprint Cedars-Sinai Medical Center cirrhosis clinical laboratory ETH Zurich lung disease M.D Malcolm Kohle Source Type: news

Sprite, Pepsi and tea tested as hangover cures
Conclusion The study has used laboratory experiments to predict what might happen when drinking alcohol with other beverages, in terms of whether the intoxicating effects of alcohol are increased or if the symptoms of a hangover are reduced. The experiments looked at the speed ethanol was metabolised and the first toxic waste product that is produced in its breakdown, acetaldehyde. While the findings are interesting – that only 2 of the 57 drinks reduced the amount of time it took to metabolise acetaldehyde – this is only one aspect of the negative effects of alcohol, and occurred in di...
Source: NHS News Feed - October 9, 2013 Category: Consumer Health News Tags: Food/diet Lifestyle/exercise Source Type: news

Alcohol and US African-American/White Cirrhosis MortalityAlcohol and US African-American/White Cirrhosis Mortality
How does cirrhosis mortality relate to alcohol consumption, and how does the association vary by race and gender? This epidemiological study looked at trends over a 53-year span. Alcohol and Alcoholism (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - September 30, 2013 Category: Consumer Health News Tags: Public Health & Prevention Journal Article Source Type: news

'Traffic light' test could prevent hundreds of people developing alcohol-related cirrhosis
A simple 'traffic light' test that detects hidden liver fibrosis and cirrhosis in high risk populations could reduce harmful drinking rates and potentially prevent hundreds of alcohol-related deaths a year. Devised by Dr Nick Sheron and colleagues at University of Southampton and Southampton General Hospital, the Southampton Traffic Light (STL) test, which costs about £50, could be used by GPs in the community... (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - September 25, 2013 Category: Consumer Health News Tags: Medical Devices / Diagnostics Source Type: news

'Traffic light' test could prevent hundreds of people developing alcohol-related cirrhosis
(University of Southampton) A simple 'traffic light' test that detects hidden liver fibrosis and cirrhosis in high risk populations could reduce harmful drinking rates and potentially prevent hundreds of alcohol-related deaths a year. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - September 24, 2013 Category: Global & Universal Source Type: news

Smartphone app found to be valid tool in screening for minimal hepatic encephalopathy
(Virginia Commonwealth University) A smartphone app can quickly screen for cognitive dysfunction often found in patients with cirrhosis, according to a new Virginia Commonwealth University study. The cognitive dysfunction, known as minimal hepatic encephalopathy, has been difficult to diagnose. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - September 18, 2013 Category: Global & Universal Source Type: news

Acetaminophen Toxicity in an Alcoholic Man
Dramatically elevated liver enzyme elevations in this man with alcoholic cirrhosis and clouded sensorium suggest a hepatocellular rather than an obstructive cause. (Source: Consultant Live)
Source: Consultant Live - August 11, 2013 Category: Primary Care Source Type: news

Alcoholic Cirrhosis and Elevated Liver Enzymes: Your Dx?
Dramatically elevated aminotransferases may be the result of medication toxicity, acute viral hepatitis, or ischemic injury to the liver. Your assessment? (Source: Consultant Live)
Source: Consultant Live - August 9, 2013 Category: Primary Care Source Type: news

WHO urges governments to act on hepatitis threat
24 July 2013 -- On World Hepatitis Day (28 July), WHO is urging governments to act against the five hepatitis viruses that can cause severe liver infections and lead to 1.4 million deaths every year. Some of these hepatitis viruses, most notably types B and C, can also lead to chronic and debilitating illnesses such as liver cancer and cirrhosis, in addition to loss of income and high medical expenses for hundreds of millions of people worldwide. (Source: WHO news)
Source: WHO news - July 24, 2013 Category: Global & Universal Source Type: news

Prescribing Medications in Patients With CirrhosisPrescribing Medications in Patients With Cirrhosis
What should clinicians understand before prescribing medications to be used by patients with cirrhosis? Alimentary Pharmacology & Therapeutics (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - June 21, 2013 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

Disruption Of Iron Uptake Receptor Identified In Hepatitis C
Hepatitis C virus (HCV) infects more than 170 million people worldwide. Approximately 80 percent of infections lead to chronic illness including fibrosis, cirrhosis, cancer and also hepatic iron overload. A new study completed by researchers at Loyola University Chicago Stritch School of Medicine reveals that HCV not only alters expression of the iron-uptake receptor known as transferrin receptor 1 (TfR1) but that TfR1 also mediates HCV entry... (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - June 12, 2013 Category: Consumer Health News Tags: Liver Disease / Hepatitis Source Type: news

'Early death map' shows English health inequality
“North and South health divide: Chilling study reveals premature death is 'postcode lottery',” the Daily Mirror reports. The news is based on a new interactive map showing the variation in premature death rates across England. The Longer Lives map, created by the new organisation Public Health England, ranks 150 local authorities by their premature death rates (deaths occurring before age 75). The interactive map also enables users to compare these areas by five common causes of premature (and potentially preventable) deaths: cancer heart disease stroke lung diseases, such as chronic obstructive pu...
Source: NHS News Feed - June 11, 2013 Category: Consumer Health News Tags: Lifestyle/exercise Heart/lungs Cancer QA articles Source Type: news

Element of the week: thorium | video | @GrrlScientist
What does toothpaste, the Norse god of thunder and the word "pyrophoric" share in common?This week, we meet thorium, a chemical element with the symbol Th and atomic number 90. This element is a bit unusual since it is the first element we've met that was named for a character in Norse mythology: it was named in honour of the Norse god of thunder (and war), Thor. Swedish chemist Jöns Jakob Berzelius initially thought he had discovered this element in 1815 but soon realised that he had misidentified yttrium phosphate as being a new element, thorium. Berzelius apparently liked the name "thorium", sin...
Source: Guardian Unlimited Science - June 7, 2013 Category: Science Authors: GrrlScientist Tags: Blogposts guardian.co.uk Science Source Type: news

Blood Tests Diagnose Fibrosis, Cirrhosis in Chronic Hepatitis CBlood Tests Diagnose Fibrosis, Cirrhosis in Chronic Hepatitis C
Several blood tests, alone and in combination, can diagnose hepatitis C virus (HCV)-related fibrosis or cirrhosis, a systematic review indicates. Reuters Health Information (Source: Medscape Gastroenterology Headlines)
Source: Medscape Gastroenterology Headlines - June 4, 2013 Category: Gastroenterology Tags: Gastroenterology News Source Type: news

Blood Tests OK for Fibrosis Dx in Hep C (CME/CE)
(MedPage Today) -- Blood testing can accurately identify clinically significant fibrosis and cirrhosis in people with hepatitis C virus infection and may be an alternative to liver biopsy in some patients, a new study found. (Source: MedPage Today Gastroenterology)
Source: MedPage Today Gastroenterology - June 3, 2013 Category: Gastroenterology Source Type: news

How to Celebrate the Life of Slayer’s Jeff Hanneman
A fitting tribute to the life of Slayer’s Jeff Hanneman would be to not have a drink in his memory.read more (Source: Psychology Today Addiction Center)
Source: Psychology Today Addiction Center - May 23, 2013 Category: Addiction Authors: William Irwin, Ph.D. Tags: Addiction Creativity Media Philosophy alcoholism american medical association band mates bloody reign cause of death cirrhosis of the liver disease of alcoholism fasciitis flesh eating disease heavy drinker Jeff Hanneman joel Source Type: news

Adverse Events Common With Triple Therapy in HCV CirrhosisAdverse Events Common With Triple Therapy in HCV Cirrhosis
In cirrhotic patients, triple-therapy against hepatitis C virus (HCV) produces a high virological response rate, but at the cost of a high rate of serious adverse events, French researchers say. Reuters Health Information (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - May 22, 2013 Category: Consumer Health News Tags: Gastroenterology News Source Type: news

Clinical Digest: Hepatitis C and Dietary Supplements
Hepatitis C, a contagious liver disease, is caused by the hepatitis C virus. People can get hepatitis C through contact with blood from a person who is already infected or, less commonly, through having sex with an infected person. The infection usually becomes chronic. Chronic hepatitis C often is treated with drugs that can eliminate the virus. This may slow or stop liver damage, but the drugs may cause side effects, and for some people, treatment is ineffective. Some people with hepatitis C also try complementary health approaches, especially dietary supplements. Several herbal supplements have been studied for hepatit...
Source: NCCAM Featured Content - May 13, 2013 Category: Complementary Medicine Authors: NCCAM Source Type: news

What Precautions Should Be Used for a Child Whose Parent is Hepatitis C Positive?
Discussion Hepatitis C virus (HCV) is a single-stranded RNA Flavivus that was first identified in 1989 and universal screening in the blood supply was begun in 1992 in the United States. Overall incidence of acute HCV in children under age 19 is 0.1 per 100,000. In adults, the transmission is mainly from contaminated blood and body fluids, primarily intravenous drug use. It is the most common reason for liver transplantation in adults. Of those that acquire the acute infection, about 70% go on to become chronically infected. Adults have a slow progression of their disease with 20% having cirrhosis within 20 years. Being ma...
Source: PediatricEducation.org - May 13, 2013 Category: Pediatrics Authors: Donna M. D'Alessandro, M.D. Tags: Uncategorized Source Type: news

Celiac Disease and Primary Biliary Cirrhosis: An Immune LinkCeliac Disease and Primary Biliary Cirrhosis: An Immune Link
What do scientists know about the connection between celiac disease and primary biliary cirrhosis, and how does this knowledge translate into treatement strategies for both diseases? Expert Review of Gastroenterology and Hepatology (Source: Medscape Gastroenterology Headlines)
Source: Medscape Gastroenterology Headlines - May 3, 2013 Category: Gastroenterology Tags: Gastroenterology Journal Article Source Type: news

Beta Blockers Ameliorate GI Permeability in CirrhosisBeta Blockers Ameliorate GI Permeability in Cirrhosis
Nonselective beta-blocker therapy improves gastrointestinal permeability, decreases intestinal bacterial translocation, and reduces variceal bleeding in patients with cirrhosis and esophageal varices. Medscape Medical News (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - May 3, 2013 Category: Consumer Health News Tags: Gastroenterology News Source Type: news

New Advances In The Management Of Patients With Cirrhosis
New data from clinical studies presented for the first time at the International Liver Congress™ 2013 provide new rationale for an old and established treatment option for portal hypertension.1 Additionally, spleen stiffness predicts the occurrence of clinical complications, which is of paramount importance in clinical practice.2 In patients with cirrhosis, increasing blood pressure in the abdominal circulatory system (known as portal hypertension) leads to potentially lethal complications which might be prevented with simple medical treatment... (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - April 30, 2013 Category: Consumer Health News Tags: Liver Disease / Hepatitis Source Type: news

Improved Screening Tests For Liver Cancer
New data from two clinical trials presented at the International Liver Congress™ 2013 demonstrate substantial improvements in the detection of both hepatocellular carcinoma (HCC) and cholangiocarcinoma (CC) using diagnostic urine tests. HCC is common throughout the world and most often develops as a late complication of chronic viral hepatitis or cirrhosis of any cause. The overall survival rate of HCC is poor and so screening for HCC offers the best hope for early detection, eligibility for treatment, and improved survival... (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - April 29, 2013 Category: Consumer Health News Tags: Liver Disease / Hepatitis Source Type: news

Triple Therapy Can Help in Advanced Hep C (CME/CE)
AMSTERDAM (MedPage Today) -- About 40% of people with advanced hepatitis C (HCV) can benefit from triple therapy even if they have cirrhosis and previous treatment failures, a researcher said here. (Source: MedPage Today Gastroenterology)
Source: MedPage Today Gastroenterology - April 28, 2013 Category: Gastroenterology Source Type: news

Hope For Improved Management Of Cirrhosis
New data from clinical studies presented for the first time at the International Liver Congress™ 2013 provide new rationale for an old and established treatment option for portal hypertension. Additionally, spleen stiffness predicts the occurrence of clinical complications, which is of paramount importance in clinical practice. In patients with cirrhosis, increasing blood pressure in the abdominal circulatory system (known as portal hypertension) leads to potentially lethal complications which might be prevented with simple medical treatment... (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - April 27, 2013 Category: Consumer Health News Tags: Liver Disease / Hepatitis Source Type: news

New advances in the management of patients with cirrhosis
(European Association for the Study of the Liver) New data from clinical studies presented for the first time at the International Liver Congress™ 2013 provide new rationale for an old and established treatment option for portal hypertension. Additionally, spleen stiffness predicts the occurrence of clinical complications, which is of paramount importance in clinical practice. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - April 25, 2013 Category: Global & Universal Source Type: news

Research May Lead To Better Treatment For Liver Disease
A certain number of patients hospitalised for cirrhosis complications soon develop a syndrome characterised by acute liver failure and/or the failure of other vital organs (ACLF). This syndrome had no specific diagnostic criteria hitherto. In this prospective study, led by Dr Richard Moreau, INSERM Research Director (Mixed Research Unit 773 "Centre de Recherche biomedicale Bichat-Beaujon"; INSERM/Universite Paris Diderot) who is also a practitioner attached to the Hepatology Department of the Beaujon Hospital (AP-HP), researchers studied a cohort of 1343 patients from 12 European countries... (Source: Health News...
Source: Health News from Medical News Today - April 22, 2013 Category: Consumer Health News Tags: Liver Disease / Hepatitis Source Type: news

Liver disease: Understanding it will enable the provision of better treatment
(INSERM (Institut national de la santé et de la recherche médicale)) A certain number of patients hospitalized for cirrhosis complications soon develop a syndrome characterized by acute liver failure and/or the failure of other vital organs. This syndrome had no specific diagnostic criteria hitherto. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - April 18, 2013 Category: Global & Universal Source Type: news

Scarring May Raise Death Risk from Fatty Liver Disease
Study looked at liver condition not tied to alcoholism Source: HealthDay Related MedlinePlus Pages: Cirrhosis, Liver Diseases (Source: MedlinePlus Health News)
Source: MedlinePlus Health News - April 16, 2013 Category: Consumer Health News Source Type: news

Liver transplantation for patients with genetic liver conditions has high survival rate
This study is a first-of-its-kind, single-institution comparison of outcomes for both pediatric and adult patients undergoing liver transplantation for lethal genetic syndromes. Researchers found that children with genetic disorders that cause fibrosis, cirrhosis, and other liver conditions, which can affect other organs, have a good chance of still being alive five -- and even 20 years after a liver transplant operation. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - April 5, 2013 Category: Global & Universal Source Type: news